Agreed, the current price is well earned. However, if they reveal they have attained BE for a high value product the price will move up. That is what has kept me here. However, I expected that BE before year end and now I am hoping for one before June 2022. Disappointing, but still holding as the potential for healthy increase exists. I can't imagine Nasrat would be dumb enough not to pursue high value generics. Maybe he is even smart enough to pursue drugs that will newly become available to be a generic about the time he gets the BE. Yes, that is a lot of hoping on my part.